News Release

News Release

News Release

View printer-friendly version << Back

Pacira Pharmaceuticals to Present at Healthcare Conferences in November

PARSIPPANY, N.J., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) today announced that members of its management team are scheduled to present at the following healthcare conferences:

  • Jefferies 2018 Healthcare Conference in London, on Wednesday, November 14, 2018 at 2:40 PM GMT (9:40 AM ET)
  • Piper Jaffray 30th Annual Healthcare Conference in New York, on Tuesday, November 27, 2018 at 12:30 PM ET

A live audio webcast of the Pacira presentations can be accessed by visiting the “Investors & Media” section of the company’s website at A replay of the webcasts will be archived on the Pacira website for two weeks following the presentation dates.

About Pacira                                                                           

Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) is a specialty pharmaceutical company dedicated to advancing and improving postsurgical outcomes for acute care practitioners and their patients. The company’s flagship product, EXPAREL® (bupivacaine liposome injectable suspension) was commercially launched in the United States in April 2012. EXPAREL utilizes DepoFoam®, a unique and proprietary product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time. To learn more about Pacira, including the corporate mission to reduce overreliance on opioids, visit

Company Contact:
Pacira Pharmaceuticals, Inc.
Christian Pedetti
(973) 254-4387


Pacira Pharmaceuticals, Inc.